Deldacan, Jana Mae A.

HRN: 29-02-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/28/2026
06/04/2026
IVT
1.5g
Q6
Acinetobacter Iwoffii/haemolyticus
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  PneumoniaURTI    Compliance to guidelines: Compliant To Guidelines